Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients

MLA

Emma Ahlén Bergman, et al. “Increased CD4+ T Cell Lineage Commitment Determined by CpG Methylation Correlates with Better Prognosis in Urinary Bladder Cancer Patients.” Clinical Epigenetics, vol. 10, no. 1, Aug. 2018, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s13148-018-0536-6.

APA

Emma Ahlén Bergman, Ciputra Adijaya Hartana, Markus Johansson, Ludvig B. Linton, Sofia Berglund, Martin Hyllienmark, Christian Lundgren, Benny Holmström, Karin Palmqvist, Johan Hansson, Farhood Alamdari, Ylva Huge, Firas Aljabery, Katrine Riklund, Malin E. Winerdal, David Krantz, A. Ali Zirakzadeh, Per Marits, Louise K. Sjöholm, … Ola Winqvist. (2018). Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients. Clinical Epigenetics, 10(1), 1–15. https://doi.org/10.1186/s13148-018-0536-6

Chicago

Emma Ahlén Bergman, Ciputra Adijaya Hartana, Markus Johansson, Ludvig B. Linton, Sofia Berglund, Martin Hyllienmark, Christian Lundgren, et al. 2018. “Increased CD4+ T Cell Lineage Commitment Determined by CpG Methylation Correlates with Better Prognosis in Urinary Bladder Cancer Patients.” Clinical Epigenetics 10 (1): 1–15. doi:10.1186/s13148-018-0536-6.